In 2024, Air Astana, Kazakhstan’s national airline, and its low-cost subsidiary FlyArystan generated $1.3 billion in revenue, a 12.4% increase year-on-year (YoY), according to the company’s statements posted on the Astana International Exchange (AIX) website. The growth was driven by passenger and cargo revenues, as well as an aircraft engine…
The world’s largest cities are overcrowded, and there is no end in sight to their growth. This makes alternatives to traditional ground transportation increasingly necessary. One of them is air taxis. In fact, JPMorgan sees the air taxi market reaching $1.0 trillion by 2040, versus just over $3.5 billion in…
Shares of biotech micro cap Equillium soared 33% yesterday, Thursday, February 6, although some of the gains have been lost before the opening bell today. The company announced that its drug for ulcerative colitis, which it is testing together with Indian pharmaceutical giant Biocon, has shown results that are no…
Quotes on the small-cap telemedicine platform Teladoc Health surged almost 6% yesterday, Wednesday, February 5, before extending the gains in premarket trading today. The trigger was an announcement that the company had signed an agreement to acquire Catapult Health, which provides at-home diagnostic kits. The deal follows a challenging period…
Shares of Zedge, a micro-cap company that offers an emoji encyclopedia, ringtones, and wallpapers for mobile phones, surged almost 11% yesterday, Wednesday, February 5, after the company announced new restructuring steps aimed at saving up to $4 million annually. Details Yesterday, Zedge advanced almost 11% on the New York Stock…
Micro-cap space services provider Sidus Space soared more than 10% yesterday, Tuesday, February 4, after an announcement that the company’s third satellite had arrived at a California space facility for final preparations ahead of launch. The mission will be carried out in collaboration with SpaceX, owned by Elon Musk, Sidus…
Quotes on the small-cap MAIA Biotechnology jumped almost 6% yesterday, Tuesday, February 4, after the company revealed phase II clinical trial results for its drug that is said to offer a fundamentally new approach to cancer treatment. The therapy has proved to be superior to existing treatments, MAIA claims, and…
Zacks Small-Cap Research (Zacks SCR) values Protalix Biotherapeutics, a small Israeli drugmaker listed in the U.S., at nearly 500% higher than its current market price. The company stands out from peers because it already generates revenue and has recently paid off its debt. This, Zacks SCR points out, takes one…
Shares of aerospace components manufacturer Triumph Group spiked 34% yesterday, Monday, February 3, and hit a nearly four-year high. The trigger was an announcement that the company would be acquired at a 38% premium by affiliates of private equity giants Berkshire Partners and Warburg Pincus. Noble Capital Markets believes the…
Shares of several small-cap suppliers of avocados took a tumble yesterday, Monday, February 3, following the announcement by President Donald Trump of new tariffs on Mexico, Canada, and China. However, the losses eased later in the day after the U.S. and Mexico agreed to a truce for a month. Note…
The Motley Fool has spotlighted two reasons to buy shares of EVgo, a smaller company that builds charging stations for electric vehicles (EVs). The U.S. EV market is growing, and even the new administration of President Donald Trump is unlikely to stifle this growth. Moreover, the company holds a competitive…
Shares of Puerto Rican consulting firm Pharma-Bio Serv have the potential to rise 150% from current levels, according to Zacks Small-Cap Research (Zacks SCR). While the company had a bumpy 2024, its management is confident negative trends will reverse in 2025. Details Pharma-Bio Serv helps pharmaceutical companies to comply with…
Chip Skinner, who manages the Royce Smaller-Companies Growth Fund, has spotlighted ACV Auctions and Cantaloupe as two “high-confidence” holdings. The fund is part of Royce Investment Partners, founded by Wall Street legend Chuck Royce, and invests in companies that, in the words of Skinner, “look poised for multi-year periods of…
Piper Sandler expects the small- and mid-cap Russell 2000 index to outgain the large-cap S&P 500 in 2025. The investment bank believes that stocks of smaller companies offer investors the “most compelling opportunities,” as the underlying businesses are bolstered by a robust labor market, rising productivity, and an overall strong…
Quotes on protective apparel manufacturer Lakeland Industries jumped almost 5% yesterday, Tuesday, January 28, after the company announced a contract with a local government procurement service in the U.S. with more than 9,000 buyers. Details Lakeland stock spiked almost 5% on the Nasdaq to $24.25 per share yesterday, before extending…
Goldman Sachs values the small-cap biotech company Vera Therapeutics at $58.00 per share, more than 60% above the current market price, as Vera’s drug candidate for autoimmune kidney diseases has shown promising results in clinical trials and is likely to hit the market next year. Details Goldman Sachs analyst Paul…
Yesterday, Monday, January 27, quotes on the small-cap oil and gas producer Diversified Energy rose 4% on the New York Stock Exchange after the company announced it had entered into an agreement to acquire peer Maverick Natural Resources for about $1.28 billion. Diversified expects the deal to nearly double its…
Shares of Canadian diamond miner Diamcor Mining have skyrocketed 300% in Frankfurt today, Tuesday, January 28. Yesterday, Diamcor surged 25% in Toronto and 65% in the U.S. (where it trades over the counter). The driver was news that Diamcor had reached a preliminary agreement with a “well-established Dubai based manufacturer…
Insider Monkey believes that now might be the best time to buy shares of smoking cessation therapy maker Achieve Life Sciences, as the stock is trading near one-year lows. That is despite the fact that the company has recently completed clinical trials for its nicotine addiction treatment and may now…
The Motley Fool warns investors against rushing into shares of Planet Labs, which has a market capitalization of $1.6 billion on the New York Stock Exchange. While the company’s strong financial performance, combined with voiced interest in space exploration by Donald Trump, has buoyed the stock, the investing advice firm…
Noble Capital Markets has identified three key factors that should buoy small-cap stocks moving forward. While the broader market reacts to macroeconomic developments like tariffs and trade policy, the small- and micro-cap space stands apart as a unique opportunity for investors, in the investment bank’s view. Recently, the Russell 2000…
In 2025, makers of drugs for Alzheimer’s disease are poised to see more interest from investors, Bloomberg reports. The number of Alzheimer’s cases is growing worldwide, and more than 160 clinical trials for Alzheimer’s treatments are currently underway. What are the most promising small caps in this niche? Market outlook…
Shares of Lakeland Industries, a manufacturer of protective clothing, slid almost 11% on Thursday, January 23, following the company’s announcement of the pricing for a planned secondary offering. It will sell 1.82 million new shares to investors at $22 apiece — the lowest price for its shares since late November.…
Ensysce Biosciences has upside of more than 250%, based on the $29.50 per share valuation of Zacks Small-Cap Research (Zacks SCR). The company is developing treatments for severe pain relief that have the power of opioids but do not carry the risk of abuse. Its products could help to put…
